Evidence map›Paper›PMID 32046520›Full record

ReviewJournal of diabetes science and technology2020

Accuracy of Blood Glucose Measurement and Blood Glucose Targets.

Gert-Jan Eerdekens, Steffen Rex, Dieter Mesotten

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gert-Jan EerdekensDepartment of Anesthesiology, University Hospitals Leuven, Belgium.ORCID 0000-0001-9973-2751
Steffen RexDepartment of Anesthesiology, University Hospitals Leuven, Belgium.
Dieter MesottenDepartment of Anesthesia and Intensive Care Medicine, ZOL-Genk, Belgium.
Ziekenhuis Oost-Limburg · BEKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo summarize new evidence regarding the methodological aspects of blood glucose control in the intensive care unit (ICU).

methodsWe reviewed the literature on blood glucose control in the ICU up to August 2019 through Ovid Medline and Pubmed.

resultsSince the publication of the Leuven studies, the benefits of glycemic control have been recognized. However, the methodology of blood glucose control, notably the blood glucose measurement accuracy and the insulin titration protocol, plays an important but underestimated role. This may partially explain the negative results of the large, pragmatic multicenter trials and made everyone realize that tight glycemic control with less-frequent glucose measurements on less accurate blood glucose meters is neither feasible nor advisable in daily practice. Blood gas analyzers remain the gold standard. New generation point-of-care blood glucose meters may be an alternative when using whole blood of critically ill patients in combination with a clinically validated insulin dosing algorithm.

conclusionWhen implementing blood glucose management in an ICU one needs to take into account the interaction between aimed glycemic target and blood glucose measurement methodology.

Indexed as

Blood Chemical AnalysisPoint-of-Care TestingBiomarkersBlood Gas AnalysisBlood GlucoseGlycemic ControlHumansHypoglycemiaHypoglycemic AgentsInsulinIntensive Care UnitsPredictive Value of TestsReproducibility of ResultsBiomarkersBlood GlucoseHypoglycemic AgentsInsulinblood glucose controlblood glucose levelintensive care unitmonitoringtight glycemic control

Identifiers

PMID32046520
PMCPMC7576954
OpenAlexW3006208375

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.